top of page
Active Protocols as Lead Node
Wave

Gail D'Onofrio, MD, MS (Co-Lead Investigator)

Andrew Herring , MD (Co-Lead Investigator) 

affiliation Pacific Northwest Node 

Gerard Carroll, MD, FAAEM, EMT-P (Co-Lead Investigator) affiliation Cooper Medical School of Rowan University

NEC Study Team Members

Marek Chawarski, PhD (Co-I)​​​

CTN-0146: A Cohort Study of Pain, Psychological, and Drug Use Outcomes of Adolescents After Major Surgery

Sharon Levy, MD, MPH (Lead Investigator)

Joseph Cravero, MD (Co-Lead Investigator) 

NEC Study Team Members

Elissa Weitzman, ScD, MSc (Co-I)​

CTN-0145: High vs Standard Buprenorphine ED Initiation

Kathryn Hawk, MD, MHS (Lead Investigator)

Andrew Herring , MD (Lead Investigator) 

affiliation Pacific Northwest Node 

Gail D'Onofrio, MD, MS (Lead Investigator) 

NEC Study Team Members

Marek Chawarski, PhD (Co-I)

​

​

​

​

Wave

David Fiellin, MD (Lead Investigator)
Paul Joudrey, MD, MPH (Co-Lead Investigator)
affiliation Appalachian Node 
NEC Study Team Members
Marek Chawarski, PhD (Co-I)
Ryan McNeil, PhD (Co-I)
​Jeanette Tetrault, MD (Co-I)
Zoe Weinstein, MD, MD (Co-I)

Kathryn McHugh, PhD (Lead Investigator)
Kathryn Hefnew, PhD (Lead Investigator)
affiliation Emmes
Rebecca Ottesen (Lead Investigator)
affiliation Emmes
Matisyahu Shulman, MD (Lead Investigator)
affiliation Emmes
 

Lead Node: New York
Roger Weiss, MD (Lead Investigator)
Edward V. Nunes, Jr., MD (Lead Investigator)
affiliation New York Node 
John Rotrosen, MD (Lead Investigator)
affiliation New York Node

Node Participation

R. Kathryn McHugh, PhD (Study Team Co-I)
Genie L. Bailey, MD (Site PI)
John Hamilton, LMFT, LADC (Site PI)
Natalie Lender, MD (Site PI)
Scott Provost, MSW, MM
(Senior Project Manager)

Completed Studies 

CTN-0079-A1 a sub-study of CTN-0099: Emergency Department INitiated upreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION) (NIH HEAL Initiative)

Ryan McCormack, MD (Lead Investigator) affiliation New York Node, Kathryn Hawk, MD, MHS (Co-Lead Investigator)

 

​CTN-0080-A2 a sub-study of CTN-0080: Qualitative interviews of pregnant patients of color with OUD

Davida Schiff, MD (Lead Investigator)

 

CTN-0099: Emergency Department INitiated bupreNOrphine and VAlidaTIOn Network Trial(ED-INNOVATION)(NIH HEAL Initiative)

Gail D’Onofrio, MD, MS (Lead Investigator), David Fiellin, MD (Lead Investigator)

NEC Study Team Members: James Dziura, MD, MHS (Co-I), E. Jennifer Edelman, MD, MHS (Co-I), â€‹Kathryn Hawk, MD, MHS (Co-I), Michael Pantalon, PhD (Co-I)​

 

CTN-0099 Supplement: Racial/Ethnic Disparities in Addiction Treatment Access for Opioid Use Disorder from the Emergency Department

​​Edouard Coupet Jr, MD, MS (Lead Investigator)

 

CTN-0099-A a sub-study of CTN-0099: Emergency Department INitiated BupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION) (NIH HEAL Initiative)

Gail D'Onofrio, MD, MS (Lead Investigator)

 

CTN-0112: Optimal Policies to Improve Methadone Maintenance Adherence Longterm (OPTIMMAL)

A. Robin Williams, MD, MBE (Lead Investigator) affiliation New York Node

NEC Study Team Members: Lynn Madden, PhD, MPA (Site Investigator)

 

CTN-0116: Pharmacist-Integrated Model of Medication Treatment for Opioid Use Disorder

Lisa Marsch, PhD (Lead Investigator) affiliation Northeast Node

NEC Study Team Members: David Fiellin, MD (Study Co-Lead Investigator)

​

CTN-0122: Comprehensive Meta-Analysis of CTN Treatment Outcomes by Race and Sex

Sarah Mennenga, PhD (Lead Investigator) affiliation New York Node

NEC Study Team Members: â€‹Angela Haeny, PhD (Co-I), Carolyn Sartor, PhD (Co-I), Shelly Greenfield, MD, MPH Co-I), R. Kathryn McHugh, PhD (Co-I)

 

CTN-0125: Integrative Data Analysis of CTN Studies to Examine the Impact of Psychosocial Treatments for Black People who use Cocaine

Kathy Burlew, PhD (Co-Lead Investigator) affiliation Ohio Valley Node , Lesia Ruglass, PhD (Co-Lead Investigator) affiliation New York Node
NEC Study Team Members: Angela Haeny PhD, Maria Crouch PhD

bottom of page